SOCS3 and non-small cell lung carcinoma: While in NSCLC, A549-drug resistance-derived exosomes can promote the parent cell proliferation, migration, invasion and enhance the drug resistance of patients to gemcitabine via the miR-222-3p/SOCS3 axis (Wei et al., 2017).